- $0 commissions
- Supports advanced order types
- Advanced technical charting
- Highly-rated customer support
| Company stock name | Merck & Company Inc |
| Stock ticker symbol | MRK |
| Exchange | NYSE |
| Open | $121.03 |
| High | $121.29 |
| Low | $119.06 |
| Close | $120.15 |
| Adjusted closing | $120.15 |
| Volume | 4,727,706 |
| 52-week stock price range | $70.74 – $124.22 | Where to buy Merck-and-Company stock | Buy on CIBC Investor's Edge |
Merck-and-Company's stock price at the last available market close was $120.15 (as of April 12, 2026). For comparison, seven days ago Merck-and-Company's stock price was $120.85. A full 30 days ago it was $115.61, and a year ago it was $79.18.
The technical analysis gauge above shows real-time buy or sell ratings and analysis for Merck-and-Company stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.
No, you cannot buy Merck-and-Company stock on the TSX because Merck-and-Company stock is not listed on the TSX. Instead, Merck-and-Company stock is listed on the NYSE under the symbol "MRK."
That said, if you're wondering how to invest in Merck-and-Company stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NYSE, like Interactive Brokers.
Merck-and-Company dividend payout ratio: 37.01% of net profits
Recently Merck-and-Company has paid out, on average, around 37.01% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.76% of the current stock value.
This means that, over a year, based on recent payouts (which are sadly no guarantee of future payouts), Merck-and-Company shareholders could enjoy a 2.76% return on their shares in the form of dividend payments. In Merck-and-Company's case, that would currently equate to about $3.24 per share.
While Merck-and-Company's payout ratio might seem fairly standard, it's worth remembering that Merck-and-Company may be investing much of the rest of its net profits in future growth.
Merck-and-Company's most recent dividend payout was on April 7, 2026. The latest dividend was paid out to all shareholders who bought their stocks by March 16, 2026 (the "ex-dividend date").
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.
The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets.
The company was founded in 1891 and is headquartered in Rahway, New Jersey.
Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.
Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling Merck-and-Company stock. The CRA taxes investment income from stocks in Canada based on three main factors:
You can learn more about the tax implications of selling stocks in Canada here.
New to Questrade? Check out available promotions and offer codes on now.
Compare six brokerage platforms to find the best platform for day trading in Canada.
Enjoy perks like free trades and cash back when you open a stock trading account with these online broker promotions.
Want to invest in learning companies and schools? We’ve put together a list of education stocks you should keep your eye on.
Want to invest in shipping and storage companies? We’ve put together a list of container stocks you should keep your eye on.
Want to invest in building companies? We’ve put together a list of construction stocks you should keep your eye on.
These are the best renewable energy stocks to buy now in Canada.
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
Buying US stocks in Canada is easier than you think. Find out how to buy US stocks in 4 simple steps.
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.